X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1274) 1274
Paper (674) 674
Publication (394) 394
Patent (212) 212
Report (196) 196
Conference Proceeding (11) 11
Book Review (6) 6
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (774) 774
experiment (734) 734
high energy physics - experiment (652) 652
particle physics (649) 649
cern lhc coll (623) 623
experimental results (615) 615
physics - high energy physics - experiment (578) 578
cms (534) 534
high energy physics (467) 467
p p: scattering (443) 443
p p: colliding beams (394) 394
physics of elementary particles and fields (367) 367
phenomenology (304) 304
13000 gev-cms (272) 272
particle physics - experiment (253) 253
scattering [p p] (234) 234
nuclear experiment (231) 231
hep (226) 226
8000 gev-cms (212) 212
chemistry (206) 206
metallurgy (206) 206
beer (197) 197
biochemistry (197) 197
compositions or test papers therefor (197) 197
condition-responsive control in microbiological orenzymological processes (197) 197
enzymology (197) 197
measuring or testing processes involving enzymes, nucleicacids or microorganisms (197) 197
microbiology (197) 197
mutation or genetic engineering (197) 197
processes of preparing such compositions (197) 197
spirits (197) 197
vinegar (197) 197
wine (197) 197
hadron-hadron scattering (196) 196
colliding beams [p p] (190) 190
background (168) 168
index medicus (135) 135
humans (124) 124
physics, particles & fields (123) 123
supersymmetry (110) 110
transverse momentum: missing-energy (96) 96
investigating or analysing materials by determining theirchemical or physical properties (88) 88
measuring (88) 88
testing (88) 88
cern lab (87) 87
elementary particles, quantum field theory (87) 87
quantum field theories, string theory (87) 87
channel cross section: upper limit (86) 86
final state:jet lepton (83) 83
astrophysics (81) 81
mutation (78) 78
quantum physics (78) 78
classical and quantum gravitation, relativity theory (77) 77
transverse momentum dependence (76) 76
high energy astrophysical phenomena (75) 75
mass dependence (75) 75
compositions thereof (71) 71
culture media (71) 71
microorganisms or enzymes (71) 71
propagating, preserving or maintaining microorganisms (71) 71
rapidity dependence (69) 69
astronomy & astrophysics (68) 68
instrumentation and detectors (68) 68
nuclear physics (67) 67
kinematics (66) 66
bottom: particle identification (64) 64
data analysis method (62) 62
jet: bottom (62) 62
cancer (61) 61
top: pair production (61) 61
female (58) 58
z0: leptonic decay (57) 57
transverse momentum (54) 54
article (52) 52
physics and astronomy (51) 51
hep-ex (50) 50
channel cross section: branching ratio: upper limit (49) 49
higgs particle: hadroproduction (49) 49
quantum chromodynamics: perturbation theory (49) 49
tumors (49) 49
male (48) 48
muon: pair production (48) 48
7000 gev-cms (47) 47
differential cross section: measured (47) 47
jet: transverse momentum (47) 47
physics, nuclear (47) 47
channel cross section: measured (46) 46
collisions (46) 46
lead (46) 46
beyond standard model (45) 45
final state:jet dilepton (45) 45
new physics: search for (45) 45
nuclear and high energy physics (45) 45
physical sciences (45) 45
rapidity (44) 44
electroweak interaction (43) 43
oncology (43) 43
science & technology (43) 43
luminosity (42) 42
mass spectrum: (42) 42
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1680) 1680
French (100) 100
German (48) 48
Chinese (8) 8
Spanish (6) 6
Japanese (3) 3
Polish (3) 3
Danish (2) 2
Korean (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 19, pp. 1835 - 1848
Journal Article
Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Bioindicators | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 26, pp. 2509 - 2520
Persons with mismatch repair–deficient tumors are more likely than persons with mismatch repair–proficient tumors to benefit from pembrolizumab — which... 
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands | Index Medicus | Abridged Index Medicus
Journal Article
Science, ISSN 0036-8075, 10/2006, Volume 314, Issue 5797, pp. 268 - 274
Journal Article
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6378, pp. 926 - 930
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2016, Volume 113, Issue 50, pp. 14330 - 14335
Journal Article
Science, ISSN 0036-8075, 10/2010, Volume 330, Issue 6001, pp. 228 - 231
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2014, Volume 111, Issue 32, pp. 11774 - 11779
Impressive responses have been observed in patients treated with checkpoint inhibitory anti-programmed cell death-1 (PD-1) or anticytotoxic... 
T lymphocytes | Tumor cell line | Myeloid cells | Medical treatment | Antibodies | Epigenetics | Cellular immunity | Mice | Tumors | Cancer | Exome | 5-azacytidine | Entinostat | Methyltransferase | HDAC | methyltransferase | MULTIDISCIPLINARY SCIENCES | TUMOR | ANTIBODY | DEPLETION | MECHANISMS | PI3K-ALPHA | entinostat | exome | IMMUNOTHERAPY | INFLAMMATION | DNA METHYLTRANSFERASE | HISTONE DEACETYLASE INHIBITORS | T-CELLS | Mammary Neoplasms, Experimental - immunology | Immunotherapy - methods | Humans | Histone Deacetylase Inhibitors - administration & dosage | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Benzamides - administration & dosage | Colorectal Neoplasms - therapy | Neoplasm Metastasis - immunology | Myeloid Cells - immunology | Female | Myeloid Cells - drug effects | Epigenesis, Genetic - drug effects | Mammary Neoplasms, Experimental - secondary | Azacitidine - administration & dosage | Neoplasm Metastasis - therapy | Pyridines - administration & dosage | Combined Modality Therapy | CTLA-4 Antigen - immunology | Mammary Neoplasms, Experimental - therapy | Neoplasm Metastasis - genetics | Animals | Colorectal Neoplasms - immunology | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Colorectal Neoplasms - secondary | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Rodents | Immunotherapy | Cytotoxicity | Metastasis | Polyclonal antibodies | Apoptosis | Index Medicus | Biological Sciences
Journal Article